MedTrace Logo

Studying Biomarkers in Samples From Patients With Rhabdomyosarcoma

NCT01433237 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2016-05-19

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research trial studies biomarkers in samples from patients with rhabdomyosarcoma.

Conditions

  • Sarcoma

Interventions

GENETIC

RNA analysis

GENETIC

gene expression analysis

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Hajime Hosoi, MD · Kyoto Prefectural University of Medicine

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2016-05-31
Completion
2016-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01433237 on ClinicalTrials.gov